SPIN1 and cancer: Previous studies also reported the potential of small-molecule inhibitors that target the ‘rigid’ Tudor-like 1 and Tudor-like 2 domains of SPIN1 in cancer treatment (Bae et al., 2017b; Xiong et al., 2019).